ArticleCancer research2020

Fibroblast-Derived IL33 Facilitates Breast Cancer Metastasis by Modifying the Immune Microenvironment and Driving Type 2 Immunity.

Ophir Shani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.